National Institutes of Health, National Cancer Institute, Division of Extramural Activities - Home Page
NIH NCI DEA Logo NIH NCI NCI/DEA
Clinical Trials and Translational Research Advisory Committee

Presentations from the 21st Meeting Held November 6, 2013
(Presentation File Format - PDF --> Get Adobe Reader)

November 6
NIH VIDEOCAST  

NCI UPDATE Dr. Doroshow
NCI Update  

LEGISLATIVE UPDATE Susan Erickson
Legislative Update  
Legislative Report  

SMALL CELL LUNG CANCER (SCLC) WORKING GROUP UPDATE ON THE WORKSHOP ON SCLC: SEIZING ON OPPORTUNITIES TO TRANSLATE RECENT RESEARCH INTO THE CLINIC FOR NEW DIAGNOSTICS AND INTERVENTIONS Dr. Rudin
Small Cell Lung Cancer (SCLC) Working Group Update on the Workshop on SCLC  

NCI NATIONAL CLINICAL TRIALS NETWORK (NCTN) WORKING GROUP UPDATE: 2013 PORTFOLIO ASSESSMENT REPORT  
NCI NCTN Working Group Update Dr. Diasio
NCI NCTN Working Group Interim Report - March 13, 2013 Dr. Sledge

PRECISION CANCER MEDICINE: EXCEPTIONAL RESPONDERS AND NCI-MATCH INITIATIVES Dr. Conley
Exceptional Responders and NCI-MATCH Initiatives  

NCI-AACR CANCER PATIENT TOBACCO USE ASSESSMENT TASK FORCE  
Tobacco Use by Cancer Patients in Clinical Trials Dr. Land
NCI-AACR Cancer Patient Tobacco Use Assessment Task Force: Research Endpoints and Topics N/A
NCI-AACR Cancer Patient Tobacco Use Assessment Task Force: Roster N/A

PATIENT REPORTED OUTCOMES-COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE)  
Incorporating Patient Reported Outcomes (PROs) in NCI-sponsored Clinical Trials (U10s) Dr. Minasian
Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Dr. Mitchell

CLINICAL TRIALS REPORTING PROGRAM (CTRP): 2013 UPDATE Dr. Prindiville
CTRP 2013 Update

INFORMATIONAL ITEMS  
Scientific Steering Committee Approved Concepts with BIQSFP (March 2006 - September 30, 2013) N/A
Summary of Steering Committee Reviewed Concepts as of September 30, 2013 N/A

Top